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ABSTRACT
Haas, Kyle D. M.S.E.C.E., Purdue University, December 2018. Transfer Learning for
Medication Adherence Prediction From Social Forums Self-Reported Data. Major
Professor: Zina Ben-Miled.
Medication non-adherence and non-compliance left unaddressed can compound
into severe medical problems for patients. Identifying patients that are likely to
become non-adherent can help reduce these problems. Despite these benefits, moni-
toring adherence at scale is cost-prohibitive. Social forums o↵er an easily accessible,
a↵ordable, and timely alternative to the traditional methods based on claims data.
This study investigates the potential of medication adherence prediction based on
social forum data for diabetes and fibromyalgia therapies by using transfer learning
from the Medical Expenditure Panel Survey (MEPS).
Predictive adherence models are developed by using both survey and social forums
data and di↵erent random forest (RF) techniques. The first of these implementations
uses binned inputs from k-means clustering. The second technique is based on ternary
trees instead of the widely used binary decision trees. These techniques are able to
handle missing data, a prevalent characteristic of social forums data.
The results of this study show that transfer learning between survey models and
social forum models is possible. Using MEPS survey data and the techniques listed
above to derive RF models, less than 5% di↵erence in accuracy was observed between
the MEPS test dataset and the social forum test dataset. Along with these RF
techniques, another RF implementation with imputed means for the missing values
was developed and shown to predict adherence for social forum patients with an
accuracy >70%.
xThis thesis shows that a model trained with verified survey data can be used
to complement traditional medical adherence models by predicting adherence from
unverified, self-reported data in a dynamic and timely manner. Furthermore, this
model provides a method for discovering objective insights from subjective social
reports. Additional investigation is needed to improve the prediction accuracy of the
proposed model and to assess biases that may be inherent to self-reported adherence
measures in social health networks.
11. INTRODUCTION
Non-adherence is one of the most costly medical expenditures. As of 2015, patients
non-adherence cost in the United States reached $290 billion dollars [1]. In addition
to being a substantial amount, this cost is a significant portion of healthcare spending
where a large proportion of the cost of non-adherence arises from prescriptions that
are never filled or not taken as prescribed [2]. While the financial losses are staggering,
the most prominent motivation for better patient adherence is saving many of the
patients whose conditions worsen due to poor compliance. Indeed, the US reported
close to 125,000 deaths related to inadequate patient adherence [3].
Predicting why and when a patient becomes non-adherent has been a topic of re-
search for decades [3, 4] and the costs and complications surrounding non-adherence
makes it a focal issue in healthcare. Traditional prediction methods often use claims
data aggregated from various health institutions. While claims data tend to be struc-
tured, they are often not accessible and may su↵er from a time lag due to the needed
pre-processing and de-identification. Social media data, on the other hand, are easily
accessible, available in real-time, and cost-e↵ective. Indeed, many studies have taken
advantage of these data to study health trends and to gain insight into large-scale
population health.
This thesis investigates multiple machine-learning models constructed from RF
classifiers. Using transfer learning, the thesis also explores the possibility of predicting
medication adherence using self-reported health information from publicly available
profiles on a social forum. In particular, we are targeting medication adherence for
two disease conditions: diabetes and fibromyalgia. These RF adherence models are
trained using survey data and shown to predict self-reported social forum adherence
measures. The contribution of this thesis consists of a model built upon accurate
survey data that can:
2• provide insights into patient adherence from unverified social forum data, and
• help define an objective measure for adherence from subjective social forum
reports.
The remainder of this thesis is organized as follows: Chapter 2 of the thesis
summarizes related work, Chapter 3 describes the methodology and the datasets
used in this study to develop the proposed models, Chapter 4 discusses the prediction
accuracy of these models, and Chapter 5 summarizes the main findings of the study
and outlines direction for future work.
32. RELATED WORK
Identifying the patients at risk and the reasons for medication non-adherence can help
guide the development of remedial and preventive plans. For many years, researchers
have stipulated that many factors can influence non-adherence [3] including: poor
patient-doctor interactions and lack of overall health understanding. The multitude
of factors and their potential interdependence make profiling patients at risk for non-
adherence di cult. Recently, the availability of large datasets from various sources
allowed the development of successful non-adherence prediction models. For instance,
Express Scripts developed a model that uses over 300 input parameters to predict
adherence [5]. These parameters include patients demographic, clinical, and genomic
features. A prediction accuracy of 98% was reported for this model with a lead-time of
6-12 months before patients stop taking their treatments [5]. Similarly, Allazo Health
[6] and FICO [7] developed data-driven medication adherence prediction models. The
latter assigns each patient a score representing the likelihood the patient will become
non-adherent. These models are based on di↵erent input features, but they all seek
to identify patients at risk of non-adherence. The focus of other research studies
related to medication adherence is on the type of data used to study adherence.
In [8], pharmaceutical retail data were compared to insurance claims data. While the
findings of [8] were inconclusive, the source and validity of the data remains to be a
topic of interest.
The use of advanced technology in predicting adherence or assisting non-adherent
patients has significantly improved. Within the past year, studies have been con-
ducted to better track and monitor non-adherent patients with the help of smart-
phones [9]. The result of these studies show that many patients better followed their
prescribed treatments when they were required to take a selfie of themselves con-
4suming their pills [9]. Improvements rates ranged from 50 to 67%. The smartphone
application used in this case relied on a machine-learning engine that analyzes the
image and validates whether or not the patient took the right treatment.
In this thesis, two prediction medication adherence models are developed for each
disease condition. Both models are based on RF [10] classifiers. RF has been success-
fully used for patient outcome related classifiers [11] primarily because of its ability
to process high dimensional feature spaces and to handle categorical features. For
instance, RF was used in [12] to predict the response of patients to various drugs.
This study showed that RF outperformed several other classification techniques over
a feature space ranging from as few as five features to as many as 1,000 features. In
another study [13], RF was used to classify patients with liver disease. This study
reports that RF outperformed other classifiers.
The methodology proposed in this thesis leverages publicly available data while
previous medication adherence models [5–7] primarily used insurance claims data.
The benefits of social media data for trend analysis in large population health have
been shown in several previous applications. For instance, twitter data have been used
to study allergen e↵ects across the United States [14] and were shown to produce a
high volume of information related to adverse event monitoring of pharmaceutical
products [15]. With regards to patient adherence, social media was used to engage
patients in order to improve their compliance [16, 17]. Predicting adherence using
social data was not previously addressed, however social media data were used to
build a machine-learning model that can correctly predict stress [18]. This study
also compared di↵erent machine learning techniques including neural networks, RF,
support vector machines, and Bayesian networks, all leading to an accuracy level
higher than 70%.
Claims data are accurate and include detailed information for each patient, while
social health data often lack accuracy due to the subjectivity of the unverifiable,
self-reported information posted by social forum participants [19]. The growth and
abundance of social data make them a valuable source of knowledge. However, using
5this data is constrained by these accuracy and validity concerns. Indeed, models
trained using social data may be learning inaccurate reports. Transfer learning can be
used to address this issue. Transfer learning is able to transfer the learning acquired in
one environment to another environment [20] thereby relaxing accuracy requirements
which are often associated with traditional machine learning methods. This approach
was successfully used in many studies, including social media applications [21, 22].
For instance, transfer learning was used to help predictive modelling of degen-
erate biological systems [23]. These systems are defined as degenerate if they are
structurally di↵erent, but yield the same output or perform the same functionality.
These output and functionality consistencies were able to translate through transfer
learning and were found to help model new biological domains.
The objective of this thesis is to complement the above-mentioned e↵orts by using
a novel transfer learning approach that can leverage social forum data. Social health
forum data can enable adherence analysis at a very large scale and with a wide
spectrum of coverage extending beyond single institutions. However, this self-reported
data may su↵er from overestimation [24] and missing values. We explore the impact
of these characteristics as well as the predictive ability of various features in the
proposed models.
63. METHODS
3.1 Data Sources
Two data sources are used to collect patient information for the proposed ad-
herence prediction models: the Medical Expenditure Panel Survey (MEPS) [25] and
PatientsLikeMe [26]. Patients from both data sources were filtered in order to ex-
tract only the patients that are taking the treatments associated with diabetes or
fibromyalgia. The list of treatments for each of these disease conditions is given in
Table 3.1. Treatments were selected if they were taken by at least a single patient on
PatientsLikeMe for the given condition.
Table 3.1: List of targeted treatments for each condition
Insulin Glargine Glimepirade Insulin Aspart
Diabetes Liraglutide Insulin Lispro Metformin
Glyburide
Fibromyalgia Zolpidem Duloxetine Pregabalin
Gabapentin Tramadol
PatientsLikeMe [26] is a public forum where patients post, discuss, and review
many of their current medications and conditions. The data collected from Patients-
LikeMe originated from the most current, publicly available treatment evaluations
and resulted in a total of 92 diabetic records and 357 fibromyalgia records. Pa-
tients provide evaluations for treatments in a structured format that includes their
self-reported adherence to the treatment. While this aspect forgoes the need for an
adherence metric, relying uniquely on the patients assessment makes the adherence
7classification subjective. This form of self-reporting from public sources has been
shown in previous studies to su↵er from overestimation [24]. This is a limitation of
the predictive models developed by using self-reported data and is the primary reason
for using transfer learning.
The second data source is the MEPS database which is provided by the Agency for
Healthcare Research and Quality (AHRQ) [25]. It is a collection of surveys assigned
to a national representing population of individuals. Participants are questioned in
a series of five rounds over a two-year interval. During each round, participants are
asked to answer a survey questionnaire that focuses on pertinent health information
consisting of health status, medical conditions, prescribed medications, insurance cov-
erage and more. Due to the span of the study, multiple panels of participants overlap.
Each year, a new panel of participants is enrolled in the study while previous year
panel finishes the second year. This panel overlap provides an insight into nationwide
dynamic changes.
The demographic breakdown mostly follows similar trends across the two disease
conditions (Table 3.2) with few di↵erences. For both diabetes and fibromyalgia, the
average social forum patient was about 5 to 10 years younger. In regards to the
region of residence, the largest variance occurs in the southern region population.
The patient population in this region was approximately 40% for both conditions
in MEPS, while no single population exceeded 30% in the social forum data set.
Females represent the majority population in all four cases (two MEPS data sets and
two forum data sets) with the fibromyalgia female population in the social forum data
set exceeding 90%.
3.2 Features
The features extracted for each patient from both data sources include:
• TOM: Type of Medication (Table 3.1)
• YTT: Years Taking Treatment
8Table 3.2: Demographic statistics for each condition
Diabetes Fibromyalgia
MEPS (3242 Samples) Social (92) MEPS (3044) Social (357)
Age 59.9 ± 14.0 54.5 ± 11.6 58.0 ± 14.9 49.1 ± 10.7
Gender
-Male 1450 (44.7%) 35 (38.0%) 995 (32.7%) 27 (7.6%)
-Female 1,703 (52.5%) 56 (60.9%) 1,944 (63.9%) 325 (91.0%)
-Not Listed 89 (2.7%) 1 (1.1%) 105 (3.4%) 5 (1.4%)
Region
-Northeast 479 (14.8%) 3 (3.3%) 400 (13.1%) 55 (13.6%)
-Midwest 668 (20.6%) 24 (26.1%) 652 (21.4%) 84 (20.8%)
-South 1,292 (39.9%) 26 (28.3%) 1,308 (43.0%) 110 (27.3%)
-West 693 (21.4%) 16 (17.4%) 561 (18.4%) 92 (22.8%)
-Not Listed 110 (3.4%) 23 (25.0%) 123 (4.0%) 16 (4.5%)
• AED: Amount Taken Each Day
• SOM: Strength of Medication (e.g., 500, 1000 mg etc.)
• OPP: Out-of-Pocket Payments (Table 3.3)
• REG: Region of Living (Northeast, Midwest, West, or South)
• AGE: Age at the end of the study, or last known age
• GEN: Gender
9One of the challenges of using multisource data is ensuring that each feature is
present in the same format in both sources. In particular, the Out-of-Pocket Payments
(OPP) feature is categorized according to Table 3.3. While MEPS gave the exact
amount paid for each prescription, the social forum data only listed ranges for OPP.
Similarly, patient records from the social forums were mapped in this study to the
appropriate US census region based on their state of residence. All MEPS records
directly list census regions.
Table 3.3: Categorization of out-of-pocket payments (OPP)
Out-of-pocket payments (per month) Quantized Value
<$25 0
$25-50 1
$50-100 2
$100 3
>$200 4
An additional data-preprocessing step was performed in the case of diabetic treat-
ments. Some diabetic medicines are in the form of injectable liquids (i.e., ml) while
others are in the form of pills (i.e., mg). Each of these types of dosage forms was
assigned its own Strength of Medication feature (i.e., SOM-mg, SOM-ml).
3.3 Target Value Assignment
The target outcome for the model is medication adherence. Patients are assigned
a value of 1 if they are adherent or 0 otherwise. As mentioned above, the social
forum dataset includes a self-reported adherence metric. Patients select one of four
adherence categories (i.e., always, usually, sometimes, or never taken as prescribed).
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For this study, the always category is mapped to the adherence class (i.e., adherence
= 1) while the other three categories are mapped to the non-adherent class (i.e.,
adherence = 0).
The MEPS survey data does not include a quantitative metric for medication ad-
herence. Therefore, a medication adherence metric was developed based on previous
studies by other researchers. In [27], eleven di↵erent medication adherence metrics
were evaluated and the study recommended Medication Refill Adherence (MRA),
which is defined as: The total days supply divided by the number of days of study
participation, multiplied by 100. For example, a patient with a total of 200 days
supplied over a period of 365 days will have an MRA of 55%. This metric can easily
be derived from the MEPS dataset for all patients. However, one of its shortcomings
is that it does not account for scenarios where patients are proactive in refilling their
prescriptions or accidentally misplace medications. In these cases, the patients MRA
value would become skewed due to the irregularity of pills supplied. Since the number
of days supply was necessary to calculate MRA, MEPS records that did not include
this parameter for a given medication were omitted. Moreover, four di↵erent thresh-
old MRA values are considered since there is no predefined correspondence between
MRA ranges and adherence. These thresholds are: 80%, 65%, 45%, and 35%.
All records containing a therapy listed in Table 3.1 for each target disease were
retrieved from panels 17-19 (2012-2015) of the MEPS dataset. The above data ex-
traction and scrubbing steps resulted in 3,242 MEPS diabetic and 3,044 MEPS fi-
bromyalgia patient records.
3.4 Classifier
The classifier model proposed for medication adherence prediction is based on
Random Forest (RF). RF consists of an ensemble of decision trees [10]. In this case,
the number of decision trees is set to 100. Consensus among the decision trees is
developed by using a technique called Bagging or Bootstrap Aggregation. That is,
11
for each tree a predefined number of records are selected randomly from the input
dataset with replacement. Based on this selection, a given record may be selected
more than once in a given tree while other records may not be selected entirely. During
the construction of each tree, a random subset of the input features is considered at
each node. In this thesis, the size of this subset was set to
p
n where n is the total
number of input features in the dataset. The randomized selection of both records
and features from the input dataset help generate unique decision trees in the RF
ensemble.
The best feature at each level of a given decision tree is determined by using the
greatest reduction in impurity [28]. The parent node in the tree always has a higher
impurity (less homogenous set of records) than all its children. A homogenous set
of records corresponds to the case were all the records belong to the same class (i.e.,
adherent class or non-adherent class). The impurity of a node [28] is defined by:
I = 1  (A+)2   (A )2 (3.1)
where, A+ and A- are the percentage of adherent and non-adherent patients pre-
sented to the node in a given tree, respectively. The change in impurity between the
parent node (p) and its left (l) and right (r) child nodes is given by:
4I = Ip   PlIl   PrIr (3.2)
where, P l and P r represent the percent of the total number of the parent records
that are mapped to the left and right branches, respectively.
In order to split the records into the appropriate right or left branches at each node,
the selected feature requires a reference value. All possible values for a given feature
are iteratively evaluated until the best split is found (i.e., branches with the lowest
impurity). In general, features can either be numeric or categorical. For instance, the
feature AGE is numeric. When AGE is used as a feature for a given node in the tree,
records that have an AGE value greater than the reference are assigned to the right
branch of the node and the remaining records are assigned to the left branch. For the
12
categorical features, such as REG, patient records that have the same value as the
reference are assigned to the right branch while the remaining records are assigned
to the left branch.
One of the limitations of the above split classification is that it does not adequately
handle patient records with missing feature values. Approximately 40% and 55% of
the fibromyalgia and diabetes patients, respectively had at least one missing entry in
the social forum dataset. A default split can be adopted in this case, where the record
with missing value is arbitrarily assigned to the left branch. Alternatively, the record
can be eliminated. Because of the prevalence of missing values in social data, the
latter alternative was not viable. A default split also does not appropriately handle
missing values. Two RF models are therefore proposed in this thesis in an attempt
to address this shortcoming.
3.4.1 Random Forest - Binning (RFB)
In the first model, all numeric features are binned using k-means clustering [29].
An additional bin is then added to represent the case when the feature value is
missing. Once the features are distributed across the bins, each node can split the
records categorically.
K-means clustering is an iterative algorithm designed to find a given number of
cluster centroids. Its heuristic approach provides a versatile and e↵ective partitioning
of a dataset. The algorithm begins by randomly selecting a defined number of means,
and assigns each sample to the nearest mean. Following this assignment, the cen-
troid is calculated and becomes the new mean for this cluster. All samples are then
reassigned to the nearest cluster mean and the process continues until the algorithm
converges to a local minimum.
In this study, there were four numeric features:
• YTT: Years Taking Treatment
• AED: Amount Taken Each Day
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• SOM: Strength of Medication
• AGE: Age at the end of the study, or last known age
These four features were assigned five bins in order to stay consistent with the
approximate number of bins for other categorical features such as OPP and REG.
In the case of AED, no clustering algorithm was used as most patients administered
their therapies 1-4 times daily. Any patient with a frequency above four was assigned
to the 4-time daily cluster. For the other three features, the centroids determined by
the k-means clustering for each disease condition are given in Table 3.4. Since this
study covers multiple knowledge domains (social forums and MEPS survey), all data
from each domain were aggregated together by feature, ensuring all feature entries
would be represented before the partitioning began.
Table 3.4: Clustering centroids for three numeric features for patient records under
a given condition
Diabetes Fibromyalgia
Bin YTT SOM AGE YTT SOM AGE
0 Missing Missing Missing Missing Missing Missing
1 1.82 yr 9922.3 mg 79.1 yr 22.1 yr 13.64 mg 62.2 yr
2 36.3 yr 500.0 mg 35.5 yr 11.64 yr 121.6 mg 77.1 yr
3 17.7 yr 5.5 mg 52.8 yr 5.41 yr 444.5 mg 49.6 yr
4 8.9 yr 39.0 mg 65.6 yr 1.04 yr 54.0 mg 33.7 yr
14
3.4.2 Random Forest - Ternary Tree (RFT)
In the second model, each node of the decision tree has three children: a left
child, a middle child, and a right child. Unlike the RFB implementation, records
with missing values are now assigned to the third child instead of being assigned to
a specific bin signifying a missing record. The advantage of the RFT model is that it
does not require additional data preprocessing as in the case of binning for the RFB
model. However, the underlying RF ensemble-learning algorithm has to be modified
in order to accommodate the additional child and to ensure that the missing value is
never selected as a reference in the split at any node. In particular, we modified the
change in impurity (Equation 3.2) to account for the addition of the third child node.
4I = Ip   PlIl   PrIr   PmIm (3.3)
3.4.3 Training/Testing using Random Forest
Classifier models are built using a training set, while their performance is evaluated
using a testing set. The training set is comprised of samples the model uses to learn
the factors that help assign these samples to their target classes. In this study, each
sample represents a unique patient record for a given treatment (Table 3.1), while
the target classes are adherent/non-adherent. Moreover, training classes are balanced
(i.e., an equal number of sample records in both classes), which ensures any knowledge
the model learns is not an artifact of a bias towards the larger represented class.
Each tree in the RF algorithm is trained using a bag of samples from the training
set. Additionally, the depth of the tree grows until the leaf nodes map to a single class
(i.e., the only samples remaining in the node are a homogeneous set of adherent/non-
adherent patients) or the leaf node can no longer split further. In most cases, the
former is true. However, there are select cases where all the remaining samples may
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have the same features characteristics in a leaf node. If this infrequent event happens,
the tree no longer grows down this branch and is treated di↵erently for the purposes
of testing.
Once the model is trained, a testing set of patient records which are independent
of the training set is used to evaluate the classifier model. This is a fundamental
component of machine-learning as this can now assess whether the model actually
learned patient adherence or whether the model may have overfit to the training
data. A good prediction accuracy for the testing set is an indication that the model
generalizes well.
Fig. 3.1: Traditional RF implementation
Testing is performed in RF by taking each sample in the testing set and traversing
each tree. Once the sample reaches to a leaf, the tree provides a single vote for
the class represented by the leaf node. After all trees have voted for a given test
sample, a collective democratic decision from the forest is made by selecting the class
with the most votes. If the leaf node of a tree is not a homogeneous set, the tree
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provides a partial vote for each class which is representative of the distribution of the
heterogeneous node. For instance, if the leaf node has one non-adherent sample and
three adherent samples, the trees provides a quarter vote for the non-adherent class
and a three-quarter vote for the adherent class.
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4. RESULTS
4.1 MRA Threshold and Class Breakdown
Transfer learning between the MEPS data and the social data is used towards
adherence prediction. Using this approach, models are trained on MEPS survey data
and then tested by using the social forum data. As previously mentioned, the MEPS
dataset does not contain a quantitative adherence measure. Therefore, adherence was
varied according to four di↵erent MRA thresholds (80%, 65%, 45%, and 35%). The
breakdown of the number of adherent/non-adherent records in the MEPS dataset for
di↵erent MRA thresholds is shown in Table 4.1. The last row of Table 4.1 also shows
the breakdown of social forum patients.
Table 4.1: Breakdown of records according to adherence/non-adherence for varying
MRA thresholds for the MEPS dataset
Diabetes Fibromyalgia
MRA Adherent Non-Adherent Percent Adherent Non-Adherent Percent
Threshold Split Split
80% 1,374 1,868 42/58 714 2,330 23/77
65% 1,698 1,544 52/48 906 2,138 30/70
45% 2,321 921 72/28 1,314 1,730 43/57
35% 2,577 665 79/21 1,571 1,473 52/48
PatientsLikeMe 70 22 76/24 281 76 79/21
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This thesis relied upon publicly available patient self reports from a health social
forum. From Table 4.1, the adherence splits for both disease conditions in the social
forum data are highly skewed towards adherent patients compared to other high
MRA threshold splits in the MEPS data. While each model tested in this study was
trained on balanced datasets, it is of note that most patients on the social forum
classify themselves as adherent, however most patient records from the MEPS survey
indicate a much more balanced adherent/non-adherent distribution.
This di↵erence may be attributed to two causes, either the social forum patients
are overestimating their adherence, or these patients who are active participants in
social health forums may be more engaged in their health which may be indicative of
a greater potential for being adherent compared to the average patient. Both of these
potential di↵erences between social forum and MEPS survey patients are considered
throughout this thesis.
4.2 Diabetes Adherence Prediction
Diabetes was selected as the first disease condition of interest. Two models were
trained at each MRA threshold listed in Table 4.1 using the two RF algorithms
described above (i.e., RFT and RFB). Samples were randomly removed from the
higher represented class in each case until a 50/50 balance between adherent and
non-adherent classes was obtained in the training dataset. For instance, 494 random
non-adherent samples were removed for the models at the MRA 80% threshold. This
process was repeated for both the 45% and 35% thresholds. The MRA 65% threshold
was close enough to an even split that no samples were removed for this training
dataset. Table 4.2 shows the number of samples used for training and testing.
Table 4.2 also shows the accuracy of the models (i.e., the number of correctly
classified test samples against the total number of samples) along with the F 1 score
which is a composite metric that represents a weighted balance between the recall
and the precision of the models. Recall accounts for the number of correctly classified
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adherent samples against the total number of actual adherent samples in the test set.
Precision is the total number of correctly classified adherent samples against the total
number of samples classified as adherent. These performance metrics are reported in
Table 4.2 for the more accurate of the two RF implementations at each threshold.
Table 4.2: MEPS diabetes test results from MEPS trained models
MRA Threshold Best Model Training Size Testing Size Accuracy F1 Score
80% RFT 2,198 550 58.9% 60.6
65% RFB 2,603 650 62.3% 66.9
45% RFB 1,424 356 61.6% 62.7
35% RFT 1,064 266 64.3% 67.6
We then selected the best performing model (RFT - 35% MRA) and tested the
model against the 92 public diabetic patient records from PatientsLikeMe. The pre-
diction accuracy for this test is 41.3% with an F 1 score of 40.6. These results show a
large di↵erence in prediction accuracy between the social forum records (41.3%) and
the MEPS records (64.3%) and appear to imply that transfer learning is not a valid
approach for social medication adherence prediction. However, this di↵erence may
be due to the small size of the social forum testing dataset.
4.3 Fibromyalgia Adherence Prediction
In order to investigate the root cause of this di↵erence, we performed the same
analysis for records with fibromyalgia therapies. As in the case of diabetes, MRA
thresholds were also varied and random samples were removed from the larger class
until the training datasets for MRA thresholds 80%, 65%, and 45% were balanced
between adherent and non-adherent classes. For the 35% MRA threshold, the distri-
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bution between the adherent and non-adherent classes was approximately balanced
in the fibromyalgia dataset. Therefore, no samples were removed from this training
dataset. The results for the fibromyalgia models are shown in Table 4.3.
Table 4.3: MEPS fibromyalgia test results from MEPS trained models
MRA Threshold Best Model Training Size Testing Size Accuracy F1 Score
80% RFT 1,143 285 70.2% 72.5
65% RFT 1,450 362 69.9% 70.0
45% RFT 2,103 525 73.0% 74.6
35% RFB 2,436 609 77.3% 79.3
The best performing model (i.e., RFB - MRA threshold 35%) in Table 4.3 was
selected and its aptitude for transfer learning was tested by using the 357 fibromyalgia
records retrieved from PatientsLikeMe. The prediction accuracy for this test is 54.9%
with an F 1 score of 65.5. As in the case of diabetes (Table 4.2), there is a large
di↵erence in prediction accuracy between the social forum test set (54.9%) and the
survey test set (77.3%).
These results for both diabetes and fibromyalgia seem to indicate that transfer
learning between survey data and social forum data is not possible. In order to under-
stand the reasons behind the failure of the above transfer learning approach, we con-
ducted an experiment to analyze the di↵erences between the models for fibromyalgia.
Diabetes was not chosen because of the limited number of PatientsLikeMe records.
4.4 Feature Investigation
In this second experiment, a model was trained on the fibromyalgia social forum
dataset. As in the case of the previous experiment, we randomly removed adherent
samples until there was a balanced distribution of 152 records in the training dataset.
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Next, we tested the model using the MEPS survey data at the 35% MRA threshold
as this threshold had the best accuracy (Table 4.3). The predictive accuracy in this
case was 55.9% with an F 1 score of 51.2. Based on the previous experiment, these low
accuracy levels were expected. However, the resulting RF model, which was trained
by using the social forum dataset, can be compared to the RF model derived from
the MEPS dataset.
The comparison between the two models was based on the number of times a
feature was traversed in the underlying RF. A percentage for each feature (PFT) was
obtained by dividing this number by the total number of nodes traversed in the RF
for all features. As described in Chapter 3, RFs are built by selecting features that
provide the greatest reduction in impurity. While there are measures that ensure that
the same feature is not selected repeatedly at each branch, the total times a feature
is selected is indicative of its relative entropy compared to other features. In an ideal
scenario, for transfer learning to be e↵ective between these domains, we expect to
see similar PFT values for each feature in the social forum model and in the survey
model. For some features this was true. However for others, the models had di↵erent
PFT values. The result of this analysis is shown in Table 4.4.
In Table 4.4, four features had less than 5% di↵erence in PFT across all four mod-
els. These features are TOM, YTT, REG and GEN. The type of medication (TOM)
being the most important feature in predicting adherence, while gender (GEN) is
the least predictive feature. The small di↵erence in PFT between these four features
indicates each model weighted these features consistently. Two additional features
(i.e., SOM and AGE) had a larger PFT di↵erence between the RFT and RFB models.
This di↵erence may be due to the binning applied to these numeric features in the
case of the RFB model. Indeed, each numeric entry is generalized during the binning.
However, the di↵erence does not explain the low performance of transfer learning
across the social forum and the survey datasets since the RFT (i.e., models 1 and 3)
models, on the one hand, and the RFB (i.e., models 2 and 4) models, on the other
hand, di↵er in accuracy by less than 5% in Table 4.4.
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Table 4.4: PFT for each feature in the fibromyalgia model. Model 1: RFT with
MRA threshold 35% using MEPS. Model 2: RFB with MRA threshold 35% using
MEPS. Model 3: RFT using social forum data. Model 4: RFB using social forum
data
Model 1 Model 2 Model 3 Model 4
TOM 24.6 26.8 24.6 26.9
YTT 12.6 11.7 12.7 10.0
AED 11.0 12.5 4.6 9.1
SOM 14.9 11.6 18.0 12.0
OPP 10.0 11.8 13.6 13.9
REG 8.2 10.2 10.2 12.3
AGE 14.5 9.6 13.8 10.5
GEN 4.5 5.8 2.4 5.4
The remaining two features (i.e., OPP and AED) in Table 4.4 were the only two
features where either both the social models had less PFT values than their survey
counterparts or vice-a-versa. This indicated a potential di↵erence between the social
forum and survey datasets. Based on this finding, we retrained the RFB and RFT
models at the 35% MRA thresholds and tested against both the survey data and
the social forum data without the OPP and AED features. The results are shown in
Table 4.5.
In the case of the new RFT model, the prediction accuracy for the social forum
test data is 68.6% compared to the 54.9% accuracy that was obtained earlier with the
RFT model trained by using all the features. Moreover, the di↵erence in prediction
accuracy between the survey test set and the social forum test set is less than 5%.
This result shows that transfer learning between adherence models developed by using
survey data and social forum is possible. However, careful consideration must be given
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Table 4.5: MEPS fibromyalgia trained models without OPP and AED
Model Testing Set Training Size Testing Size Accuracy F1 Score
RFT MRA 35 MEPS 2,436 609 73.5% 74.4
RFT MRA 35 Social Forum 2,436 357 68.6% 80.4
RFB MRA 35 MEPS 2,436 609 73.5% 76.0
RFB MRA 35 Social Forum 2,436 357 63.9% 75.3
to the features that are used to construct the model. Indeed, removing OPP and AED
improved the prediction accuracy of the transfer learning for the social forum models.
However, as evident by Table 4.3 and Table 4.5, the prediction accuracy decreased
for the MEPS test set (77.3% to 73.5%). This result illustrates the benefit of a larger
feature space, but also demonstrates that some features may not share a one-to-one
relationship between the social and survey domains.
Additional investigation is needed in order to determine why removing these fea-
tures improved the performance of the social forum models. We speculate that this
may be due to over/under estimation by the patients [18] and to di↵erences in the
socio-demographic distribution of the patients. For instance, 80% of the MEPS pa-
tients had an OPP <$25 each month, whereas less than 40% of the social forum
patients had an OPP <$25. Now that the AED and OPP features were removed, we
updated the PFT values for the new models in in Table 4.6. All models that shared
the same domain illustrated consistent PFT values (<5%).
As discussed earlier, the di↵erence between the adherent distributions (Table 4.1)
of the social forum and MEPS data are due to social forum patients either providing
false adherence reports or being naturally more engaged in their healthcare. From
the results of this study, it appears the latter is more indicative of the truth than the
former. If patients were providing false self-reports there would be a stark di↵erence
between the results from the survey and social forums testing sets. For the RF model,
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Table 4.6: PFT for each feature in the fibromyalgia model following the removal of
AED and OPP. Model 1: RFT with MRA threshold 35% using MEPS. Model 2:
RFB with MRA threshold 35% using MEPS. Model 3: RFT using social forum
data. Model 4: RFB using social forum data
Model 1 Model 2 Model 3 Model 4
TOM 29.3 33.2 25.2 29.5
YTT 16.2 16.0 17.4 14.4
SOM 18.5 15.0 20.2 17.2
REG 10.7 14.1 13.2 16.7
AGE 20.1 13.6 20.4 14.2
GEN 5.2 7.9 3.4 7.9
the di↵erence between the survey and social forum test sets was 5%. This small error
may be attributed to minor over-estimations and in general, the model identified most
of these self-identified adherent patients on the social platform as adherent.
4.5 Additional Features
While refining the feature space improved the social adherence prediction from
transfer learning, there was a reduction in performance in the survey test sets (77.3%
to 73.5%) merely by removing two features. This result prompted the question of
whether other features exist that can aid in improving adherence prediction. Cur-
rently, social forums do not typically ask questions beyond the feature space presented
in this work, but if other features have a substantial impact on adherence prediction,
social forums may be more inclined to request this information from participants.
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The MEPS survey data provides a greater depth of patient information compared
to the social forum data. Altogether, five more patient features were added to the
model which were not present in any public patient treatment evaluation on the social
forum. For this reason, only the MEPS test sets were evaluated in this experiment.
The features are:
• RACE: Patient Race/Ethnicity
• DVS: Number of Dental Visits through all Rounds
• CND: Number of Documented Conditions
• EVS: Number of Emergency Room Visits Through all Rounds
• RET: Has a Retirement Plan
Furthermore, only the diabetic records were considered as these models did not
perform as well as the fibromyalgia models and the hope was for these new features
to provide additional insight into adherence prediction for diabetic patients. All the
features were binned using the same k-means clustering procedure detailed in Section
3.4.1. These bins are shown in Table 4.7.
Table 4.7: Clustering centroids for six numeric features in MEPS Diabetes Model
with additional features
Bin YTT SOM AGE DVS EVS CND
0 Missing Missing Missing Missing Missing Missing
1 23.69 yr 37.13 mg 78.3 yr 20.2 4.8 6.4
2 11.34 yr 500.0 mg 64.9 yr 5.95 20 13.8
3 4.65 yr 975.8 mg 52.1 yr 10.6 1.5 35.8
4 0.9 yr 5.52 mg 34.7 yr 2.1 9.7 22.7
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The experiment produced mixed results. Indeed, as seen from Table 4.8, while the
accuracy increased at the 35% and 45% thresholds, in the case of the 80% threshold
the performance is nearly identical and for the 65% threshold the performance actually
decreased. These results appear to indicate that the five new features (RACE, DVS,
EVS, CND, and RET) have little impact on adherence prediction, or that these
features provide no new insight beyond what the model is able to learn from the
original features.
Table 4.8: Comparison between the performance of the original MEPS model
against the new MEPS model with additional features
Original Diabetes Model with
Diabetes Model Five New Features
MRA Best Model Accuracy F1 Score Best Model Accuracy F1 Score
80 RFT 58.9% 60.6 RFT 59.3% 60.4
65 RFB 62.3% 66.9 RFB 57.3% 62.3
45 RFB 61.6% 62.7 RFT 67.1% 69.4
35 RFT 64.3% 67.6 RFT 69.2% 70.3
4.6 Multi-Class Analysis
While a binary prediction for adherence provides substantial insight into patient
compliance, many patients are not strictly adherent/non-adherent but represent vary-
ing degrees of compliance. For this reason, the model responsible for illustrating the
potential for transfer learning (Table 4.5) was altered to accommodate additional
classes. Indeed, these new classes provide a more refined prediction into patient
medication adherence compliance.
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As discussed in Chapter 2, the social forums allowed participants to self report
which of the four varying degrees of adherence they believed described their adherence
level (always, usually, sometimes, never taken as prescribed). Having used four vary-
ing MRA thresholds (80%, 65%, 45%, 35) for the MEPS data, each MEPS patient
was assigned a level of adherence similar to that of the social patient. The mapping
between the threshold and the new adherence target is given below:
• MRA thresholds >80: Always
• MRA thresholds <80 and >65: Usually
• MRA thresholds <65 and >45: Sometimes
• MRA thresholds <45: Never Taken as Prescribed
The class breakdown for each new adherence level is shown in Table 4.9.
Table 4.9: MEPS fibromyalgia breakdown for each of the four classes
Class Breakdown for Fibromyalgia Records
Threshold MRA 80% MRA 65% MRA 45% MRA 35%
Level Always Usually Sometimes Never Taken as Prescribed
Patients 714 192 408 1730
After class balancing, new models were trained using multi-class targets. Since a
better performance for MEPS data was found with features AED and OPP (Table
4.5), two di↵erent models were created, one with these features and one without. The
results for the MEPS test sets are given in Table 4.10. Even against a randomly guess-
ing model (expected accuracy is 25%) the best of the four-class models only learned
approximately 8% more information regarding adherence. This low performance may
be attributed to the availability of a limited number of training samples as a result
of class balancing and the reduced number of samples per class.
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Table 4.10: MEPS fibromyalgia trained models with four class targets
Best Model Training Size Testing Size Accuracy
Without AED & OPP RFT 616 152 28.9%
With AED & OPP RFB 616 152 32.9%
In order to further investigate if poor performance is due to the limited number
of samples in the training set, both the middle classes (usually, and sometimes) were
combined resulting in a model with three classes. These two classes had the lowest
number of samples (Table 4.9). The same training and testing procedure was then
applied and the corresponding results are shown in Table 4.11.
Table 4.11: MEPS fibromyalgia trained models with three class targets
Best Model Training Size Testing Size Accuracy
Without AED & OPP RFT 1440 360 49.2%
With AED & OPP RFT 1440 360 50.0%
The three-class models (Table 4.11) have a better performance than their four-
class model (Table 4.10) counterparts. Compared against a randomly guessing model
( 33%), the best model learned approximately 17% more information related to patient
adherence. While this result is not significantly larger, it illustrates the potential for
a more refined patient adherence multi-class model. The accuracy of each class in the
multi-class model is shown in Table 4.12. The results indicate the middle class has
the worst predictive accuracy of the three classes. The model is better at identifying
patients on di↵erent ends of the adherence spectrum, namely very compliant patients
and patients who never take their medications as prescribed.
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Table 4.12: Accuracy distribution across each of the three classes
Model ”Always” Class ”Sometimes/Usually” ”Never Taken as
Accuracy Accuracy Class Accuracy Prescribed” Class Accuracy
Without AED & OPP 49.2% 70.0% 29.7% 51.9%
With AED & OPP 50.0% 66.0% 32.0% 55.0%
Table 4.13: PFT value comparison between the three class model and the binary
target class model counterpart
With AED & OPP Without AED & OPP
RFT 3 Class RFT 3 Class
TOM 24.6 25.1 29.3 28.8
YTT 12.6 13.9 16.2 17.1
SOM 14.9 13.9 18.5 18.1
REG 8.2 8.8 10.7 10.7
AGE 14.5 14.7 20.1 20.5
GEN 4.5 4.5 5.2 4.8
AED 11.0 10.4
OPP 10.0 8.7
With respect to the predictive features, the three class model PFT values com-
pared to the RFT binary class model is shown in Table 4.13. The largest di↵erence
between the PFT of the two models was for the YTT feature for the models with
AED and OPP, and the di↵erence was only 1.3%.
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4.7 RF with Imputed Means
As stated in Chapter 3, at least 40% of all the patients in the social forum for both
disease conditions had at least one missing value. In order to properly predict patient
adherence from a data source with a high prevalence of missing data, two modified
approaches(RFB and RFT) using an RF classifier were presented. RFB required a
pre-processing step where all features were binned using k-means clustering, and the
missing values were placed in a separate bin. RFT did not require any pre-processing
but did require a modification to the core algorithm where all missing values split
into a separate third child. Indeed, both of these methods provided a process for
handling missing values, without making an assumption about their values, while
still di↵erentiating them from known entries values.
An alternative to the above two approaches, considers imputing the missing values
with the mean of the given feature. The results of the imputed means RF (IMRF)
against the results presented in Tables 4.2 and 4.3 for RFT and RFB are shown in
Table 4.14.
Table 4.14: The performance of IMRF compared to the previous RFT/RFB models.
All models are trained using MEPS diabetes and fibromyalgia patients
Diabetes Fibromyalgia
MRA IMRF RFT/RFB IMRF RFT/RFB
Accuracy F1 Accuracy F1 Accuracy F1 Accuracy F1
80% 57.4% 61.9 58.9% 60.6 74.0% 75.5 70.2% 72.5
65% 56.4% 57.4 62.3% 66.9 76.8% 77.4 69.9% 70.0
45% 59.8% 59.8 61.6% 62.7 75.0% 75.1 73.0% 74.6
35% 65.8% 69.2 64.3% 67.6 75.0% 75.4 77.3% 79.3
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Table 4.14, shows that IMRF is another viable RF implementation for adherence
prediction. Moreover, the accuracy of IMRF is comparable to that of the RFT and
RFB models. As in the previous procedure, both the AED and OPP features were
removed from the best performing fibromyalgia model (MRA-65%) and the model was
retrained and tested against a MEPS test and a social forum test set. The results are
shown in Table 4.15.
Table 4.15: Comparison between MEPS IMRF and RFT fibromyalgia trained
models without OPP and AED
Model Testing Set Training Size Testing Size Accuracy F1 Score
RFT MRA 35 MEPS 2,436 609 73.5% 74.4
RFT MRA 35 Social Forum 2,436 357 68.6% 80.4
IMRF MRA 65 MEPS 1,450 352 77.9% 77.8
IMRF MRA 65 Social Forum 1,450 357 73.7% 79.4
The IMRF implementation is a better model for transfer learning than the RFT
models. However, compared to RFT and RFB models, the IMRF is more sensitive
to missing values as imputation cannot be used for a large number of records.
The PFT values of the IMRF models remained consistent between survey and
social trained models as well as consistent with the RFT and RFB models. Table
4.16 shows the PFT values for all three models (RFT, RFB, and IMRF) in each
domain for fibromyalgia.
The benefit of the RFB and RFT models is that they do not change the distribu-
tion of the data. Therefore, a mixed-mode model should be considered for features
with a limited number of missing values. For features with a larger number of miss-
ing features either RFT or RFB should be used. This mixed-mode model will be
investigated as part of future work.
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Table 4.16: PFT for each feature in the fibromyalgia model following the removal of
AED and OPP. Model 1: RFT with MRA threshold 35% using MEPS. Model 2:
RFB with MRA threshold 35% using MEPS. Model 3: RFT using social forum
data. Model 4: RFB using social forum data. Model 5: IMRF with MRA threshold
65%. Model 6: IMRF using social forum data.
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
TOM 29.3 33.2 25.2 29.5 30.8 26.0
YTT 16.2 16.0 17.4 14.4 15.7 16.9
SOM 18.5 15.0 20.2 17.2 19.0 19.7
REG 10.7 14.1 13.2 16.7 10.4 11.0
AGE 20.1 13.6 20.4 14.2 19.3 22.5
GEN 5.2 7.9 3.4 7.9 4.8 3.8
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5. CONCLUSION
A medication adherence prediction model was developed using MEPS survey data.
This model was then tested on patients from the social forum PatientsLikeMe. While
there were no clear demographic di↵erences, we did not have access to other features
such as race, education, or social status in the social forum dataset. Moreover, all
the social forum records came from public profiles originating from only one source,
PatientsLikeMe. A more comprehensive investigation will cover data aggregated from
multiple public institutions. Moreover, while modified implementations and numerical
methods were used to account for missing entries, many patients from the social form
site contained at least one unknown entry.
Despite possible inconsistency in the social and demographic distribution of the
two patient populations, the results show that using transfer learning between these
two environments is possible. That is, a model trained using accurate but limited
survey data can then be used to predict adherence from social forum data, which is
available at scale and in a timely manner. Also, due to the large amount of adher-
ent responses on the social platform, and the model identifying them as adherent,
these results infer that many of these patients are not providing false reports and are
actually more engaged in their healthcare than the average patient.
One of the reasons for successful transfer learning between these two domains
can be attributed to the feature space used to predict adherence. Indeed, many of
the patient features provided to the models were features that many social forum
patients responded to accurately. For example, with features such as: AGE, GEN,
REG, TOM, etc..., unless the patient is blatantly providing false information, the
responses to these features are unambiguous. Whereas with OPP, one of the features
that did not transfer between the two domains, many patients are taking multiple
therapies and unless each patient is carefully documenting the average cost of each
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specific therapy, false responses towards OPP is highly likely. This result also indicates
that transfer learning may not be possible for all the features. In addition to OPP
for the above reasons, AED also did not transfer between the two domains. Omitting
these features improved the adherence prediction accuracy for social forum patients
with models that are trained by using survey data.
This study did not find a single MRA threshold that proved to universally provide
the best adherence prediction. For both diabetes and fibromyalgia models under the
RFB and RFT implementations, the best performance in accuracy was observed at
the 35% MRA threshold, while the IMRF implementation produced the best model
for fibromyalgia at the 65% MRA threshold. A higher predictive performance at lower
thresholds indicate models are better at di↵erentiating between patients who rarely
take their treatments, against all other patients. The inverse is true for all the models
that are more accurate at higher MRA threshold predictions.
Finally, of all the RF implementations, the IMRF model produced the best results
for social forum adherence prediction using transfer learning. However, the disadvan-
tage for using imputed means is that it changes the entropy of the data. While it may
have been e↵ective in this case, this implementation may not be as scalable as the
other RF implementations since social data is prone to missing data. One of the core
objectives for this thesis is to develop a scalable and cost-e↵ective approach to adher-
ence prediction. The IMRF models may not comply with the very reason social data
was selected. Based on the results of this thesis, RFT and RFB are recommended for
social adherence prediction applications. A hybrid approach that combines imputed
means and either RFT or RFB will be considered in future work.
Future work will also consider aggregating public data from other social sites and
investigating temporal adherence prediction. This thesis appropriately identifies ”if”
patients will become adherent. An extension to this work could identify time to non-
adherence. This can help support preventative measures for patients that are at risk
for becoming non-adherent.
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